Health In Tech, Inc. (HIT) Stock

About Health In Tech, Inc.

Health In Tech, Inc. is led by CEO Tim Johnson, employs 73 people, headquartered in US, publicly traded since 2024.

Health In Tech, Inc. (HIT) stock trades at $0.56 with a market capitalization of $30.14M. The stock is valued at a negative price-to-earnings (P/E) ratio of -11.11, reflecting a net loss over the last twelve months, price-to-book of 2.52, price-to-sales of 1.29. Over the past 52 weeks the stock has ranged between $0.52 and $4.02, and currently trades 86.1% below its 52-week high.

On profitability, Health In Tech, Inc. generates a return on equity (ROE) of -20.95% (negative, reflecting a net loss), return on capital employed of -25.03%, an operating margin of 6.06%, a net profit margin of -12.03%.

Health In Tech, Inc. by the numbers, 2022–2025

Between 2022 and 2025 Health In Tech, Inc. reported revenue of $6.0M rising to $33.0M, a change of +450.0% across 4 years. Compounded, revenue has grown —% a year over five years, 76.5% over three, 73.7% over the last twelve months. Net profit was $1.0M in 2025.

Operating margin went from 3.6% in 2022 to 4.6% in 2025, a gain of 1.0 percentage points. The most recent net margin is -12.03%. On a trailing twelve-month basis to Jun '26, revenue is $33.0M and net profit $-5.0M.

Borrowings stand at $0, cash from operations was $3.0M in the latest year, positive in 4 of the last 4.

Return on equity has averaged 11.7% over five years, and was 5.9% in the most recent year.

The share price itself has compounded at —% a year over five years, —% over three, —% over the last year. Past price movement is history, not a forecast.

Figures are as reported and in the company's own reporting currency. They describe what has already happened and carry no implication about what follows.

Health In Tech, Inc. (HIT) — frequently asked questions